Predictors of spontaneous transient seizure remission in patients of medically refractory epilepsy due to mesial temporal sclerosis (MTS)

被引:1
作者
Dhiman, Vikas [1 ,2 ]
Sinha, Sanjib [2 ]
Arimappamagan, Arivazhagan [3 ]
Mahadevan, Anita [4 ]
Bharath, Rose Dawn [5 ]
Saini, Jitender [5 ]
Rajeswaran, Jamuna [6 ]
Rao, Malta Bhaskar [3 ]
Shankar, Susrala K. [4 ]
Satishchandra, Parathasarthy [2 ]
机构
[1] Natl Inst Mental Hlth & Neurosci, Dept Clin Neurosci, Bangalore 560029, Karnataka, India
[2] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India
[3] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India
[4] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India
[5] Natl Inst Mental Hlth & Neurosci, Neuroimaging & Intervent Radiol, Bangalore 560029, Karnataka, India
[6] Natl Inst Mental Hlth & Neurosci, Dept Neuropsychol, Bangalore 560029, Karnataka, India
关键词
Drug resistant epilepsy; Mesial temporal sclerosis; Seizure remission; TLE; HIPPOCAMPAL SCLEROSIS; LOBE EPILEPSY; PROGNOSTIC-FACTOR; ILAE COMMISSION; TASK-FORCE; TRIAL;
D O I
10.1016/j.eplepsyres.2014.11.018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: To analyze the predictors of spontaneous transient seizure remission for >= 1 year in patients with drug-resistant epilepsy (DRE) due to mesial temporal sclerosis (MTS). Methods: This analysis included 38 patients with DRE (M:F =20:18, age: 31.7 +/- 10.9 years) diagnosed with unilateral MTS (right:left = 16:22). Group I ('remission' group) comprised of patients with seizure remission (M:F =10:8, age: 32.8 +/- 12.3 years, mean seizure free period: 2.2 +/- 1.1 years; median: 2.1 years). Group II ('non-remission' group) comprised of age and gender matched 20 patients (M:F = 10:10, age: 30.7 +/- 9.7 years) with unilateral MTS who never had seizure remission and subsequently underwent epilepsy surgery. Groups I and II were compared to find the predictors associated with transient seizure remission. Results: The age at onset of seizures in group I was 13.2 +/- 11.8 years and in group II was 12.0 +/- 7.6 years. The duration of seizure was: group I - 19.7 +/- 12.5 years and group II - 19.3 +/- 7.7 years. Past history of seizure remissions (p < 0.001), frequent periods of remissions (p <0.001), first remission within a year of onset of seizures (p= 0.04) and normal EEG (p = 0.04) were the important clinical predictors associated with seizure remission in this cohort. Fifteen patients in group I (83.3%) experienced remission following either change in AED (p <= 0.001) or increase in AED dosages (p <0.001). There was no difference between the two groups regarding the type of semiology (partial vs. secondarily generalized) (p = 0.50), family history of seizures (p = 1.0), side of the lesion (p = 0.34), history of febrile seizures (p = 1.0) and the number of AEDs used (p = 0.53). Conclusion: The present study unfolds, some of the clinically relevant predictors associated with transient seizure remission in patients with DRE and MTS. Future molecular and network studies are required to understand its mechanism. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 25 条
  • [1] Patient-reported cognitive side effects of antiepileptic drugs: Predictors and comparison of all commonly used antiepileptic drugs
    Arif, Hiba
    Buchsbaum, Richard
    Weintraub, David
    Pierro, Joanna
    Resor, Stanley R., Jr.
    Hirsch, Lawrence J.
    [J]. EPILEPSY & BEHAVIOR, 2009, 14 (01) : 202 - 209
  • [2] Defining early seizure outcomes in pediatric epilepsy: the good, the bad and the in-between
    Berg, AT
    Shinnar, S
    Levy, SR
    Testa, FM
    Smith-Rapaport, S
    Beckerman, B
    Ebrahimi, N
    [J]. EPILEPSY RESEARCH, 2001, 43 (01) : 75 - 84
  • [3] HIPPOCAMPAL SCLEROSIS IN TEMPORAL-LOBE EPILEPSY DEMONSTRATED BY MAGNETIC-RESONANCE-IMAGING
    BERKOVIC, SF
    ANDERMANN, F
    OLIVIER, A
    ETHIER, R
    MELANSON, D
    ROBITAILLE, Y
    KUZNIECKY, R
    PETERS, T
    FEINDEL, W
    [J]. ANNALS OF NEUROLOGY, 1991, 29 (02) : 175 - 182
  • [4] International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: A Task Force report from the ILAE Commission on Diagnostic Methods
    Bluemcke, Ingmar
    Thom, Maria
    Aronica, Eleonora
    Armstrong, Dawna D.
    Bartolomei, Fabrice
    Bernasconi, Andrea
    Bernasconi, Neda
    Bien, Christian G.
    Cendes, Fernando
    Coras, Roland
    Cross, J. Helen
    Jacques, Thomas S.
    Kahane, Philippe
    Mathern, Gary W.
    Miyata, Haijme
    Moshe, Solomon L.
    Oz, Buge
    Oezkara, Cigdem
    Perucca, Emilio
    Sisodiya, Sanjay
    Wiebe, Samuel
    Spreafico, Roberto
    [J]. EPILEPSIA, 2013, 54 (07) : 1315 - 1329
  • [5] Antiepileptic drug therapy: When is epilepsy truly intractable?
    Camfield, PR
    Camfield, CS
    [J]. EPILEPSIA, 1996, 37 : S60 - S65
  • [6] Seizure remission in adults with long-standing intractable epilepsy: An extended follow-up
    Choi, Hyunmi
    Heiman, Gary A.
    Clary, Heidi Munger
    Etienne, Mill
    Resor, Stanley R.
    Hauser, W. Allen
    [J]. EPILEPSY RESEARCH, 2011, 93 (2-3) : 115 - 119
  • [7] Response to first drug trial predicts outcome in childhood temporal lobe epilepsy
    Dlugos, DJ
    Sammel, MD
    Strom, BL
    Farrar, JT
    [J]. NEUROLOGY, 2001, 57 (12) : 2259 - 2264
  • [8] UPDATE ON SURGICAL-TREATMENT OF THE EPILEPSIES - SUMMARY OF THE 2ND INTERNATIONAL PALM DESERT CONFERENCE ON THE SURGICAL-TREATMENT OF THE EPILEPSIES (1992)
    ENGEL, J
    [J]. NEUROLOGY, 1993, 43 (08) : 1612 - 1617
  • [9] Prognostic factor for medical control for seizures in patients with radiologic evidence for mesial temporal lobe sclerosis
    Falip, M
    Gratacós, M
    Santamarina, E
    Rovira, R
    Padró, LL
    [J]. REVISTA DE NEUROLOGIA, 2003, 36 (06) : 501 - 506
  • [10] IS EPILEPSY A PROGRESSIVE DISORDER
    GIRVIN, JP
    [J]. JOURNAL OF EPILEPSY, 1992, 5 (02): : 94 - 104